Cover Image
市場調查報告書

類風濕性關節炎:全球臨床實驗檢討

Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318825
出版日期 內容資訊 英文 188 Pages
訂單完成後即時交付
價格
Back to Top
類風濕性關節炎:全球臨床實驗檢討 Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 188 Pages
簡介

本報告提供類風濕性關節炎的臨床試驗相關的基本資料和數據,提供您實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • 類風濕性關節炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5個國家的臨床實驗數量
    • 中南美主要5個國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上類風濕性關節炎所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:免疫疾病治療藥臨床實驗上類風濕性關節炎所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

類風濕性關節炎治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞 類風濕性關節炎

臨床實驗簡介

  • 主要企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Pfizer Inc.
    • AbbVie Inc.
    • Bristol-Myers Squibb Company
    • AstraZeneca PLC
    • Johnson & Johnson
    • C. H. Boehringer Sohn AG & Co. KG
    • Amgen Inc.
    • Merck & Co., Inc.
    • UCB S.A.
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Institute of Arthritis and Musculoskeletal and Skin Diseases
    • Academic Medical Center
    • 大阪市立大學
    • 產業醫科大學
    • University of Leeds
    • Leiden University Medical Center
    • University of California, Los Angeles
    • Department of Health, UK
    • 琦玉醫科大學
    • Tabriz University of Medical Sciences

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2407CTIDB

GlobalData's clinical trial report, "Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014" provides data on the Rheumatoid Arthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rheumatoid Arthritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Rheumatoid Arthritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Rheumatoid Arthritis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Rheumatoid Arthritis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Rheumatoid Arthritis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Rheumatoid Arthritis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Rheumatoid Arthritis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Rheumatoid Arthritis
    • Oct 23, 2014: ABLYNX'S ANTI-IL-6R Nanobody Partnered With Abbvie Demonstrates A Bioavailability Of More Than 80% After Subcutaneous Injection
    • Sep 29, 2014: Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction
    • Sep 23, 2014: EPIRUS Announces Positive 58 Week Follow up Data for BOW015 for Treatment of Rheumatoid Arthritis
    • Sep 18, 2014: Galapagos reports high participation rate in long term extension study with GLPG0634 in RA patients
    • Sep 09, 2014: Biotest completes recruitment in Phase IIb study (TREAT 2b) of Tregalizumab (BT-061) in patients with rheumatoid arthritis
    • Sep 03, 2014: Protalex Announces Acceptance of Abstract Highlighting Findings from U.S. Phase 1(b) Trial of PRTX-100 in Active Rheumatoid Arthritis Patients at the 2014 American College of Rheumatology Annual Meeting
    • Aug 18, 2014: Initiation of Phase 3 Trial of CHS-0214 (Investigational Etanercept Biosimilar) in Japan (RApsody)
    • Aug 14, 2014: Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint in Pivotal Pharmacokinetic Clinical Study
    • Aug 06, 2014: New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis Patients
    • Aug 05, 2014: Novimmune Reports Successful Completion of Phase I trial for NI-0101
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • UCB S.A.
      • Clinical Trial Overview of UCB S.A.
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Osaka City University
      • Clinical Trial Overview of Osaka City University
      • University of Occupational and Environmental Health, Japan
      • Clinical Trial Overview of University of Occupational and Environmental Health, Japan
      • University of Leeds
      • Clinical Trial Overview of University of Leeds
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
      • Department of Health, UK
      • Clinical Trial Overview of Department of Health, UK
      • Saitama Medical University
      • Clinical Trial Overview of Saitama Medical University
      • Tabriz University of Medical Sciences
      • Clinical Trial Overview of Tabriz University of Medical Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka City University, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Occupational and Environmental Health, Japan, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leeds, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2014*

List of Figures

  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top